Going by the few reports we have so far, i think this chemical is going to be a bit of a let down. It seems to have been completely overhyped unfortunatley, but only time will tell if the reports are legitimate (Although i can't see vendors rating their products anything less than mind blowing).
Well, we dont even know if the current batch being solled any good as it come out much faster before all the other vendors. I personally still think it can be wonderfull chemical looking at its releasing properties.
Also the example that MDAI was disappointing doesnt mean much, its just a serotonin releaser, if you find it disappointing you were just expecting too much from simple serotonin release, this has nothing to do with looking good on paper and then being disappointing in real life.
True, and as pointed out above, there's no way to prove what has been sampled so far is even 5-IAI.
Not sure if the MDAI thing was directed at me but i've yet to sample it myself, and even though alot of people are dissapointed with it's effects i think i sounds like something i could personaly enjoy.
One of the reports saying it was disappointing was someone redosing as if it was Mephedrone so its no wonder it didn't work. Its going to have to be treated more like MDMA i should think.
Hi. I have a small amount of what I believe to be the substance (it was sold as 5-IAI), and I'm prepared to try it and post a report. First I want to check if what I've got sounds safe (relatively).
It is an off-white powder, slightly yellow hue, which I think could be a sign of impurities not being properly removed during manufacture?
It smells a little fishy, which I think might be down to the amine group or similar impurities.
Putting a very small amount on the end of my tongue gave a sharp sensation similar to a burn, which faded to a tingle after about 5 seconds, which then lasts several minutes. The taste is sharp, chemical, bitter, and definitely different to mephedrone yet along the same lines.
Can anyone say how this compares to their own? And any comments on the safety of the substance based on my description would be appreciated, especially regarding impurities.
Well, we dont even know if the current batch being solled any good as it come out much faster before all the other vendors. I personally still think it can be wonderfull chemical looking at its releasing properties.
Also the example that MDAI was disappointing doesnt mean much, its just a serotonin releaser, if you find it disappointing you were just expecting too much from simple serotonin release, this has nothing to do with looking good on paper and then being disappointing in real life.
if what they are saying is true and it "fully substitutes for MDMA in rodents and is a putative entactogen in humans" could make this new RC very interesting indeed, especially with the low toxicity.
mdai also did fully substitute for mdma in rodents.
and toxicity-wise 5-iai is compared to 4-iodo-amphetamine, which is being used in the lab to selectively kill serotonogenic neurons. i'd be careful around this one and wait until more reports (and research) are available.
mdai also did fully substitute for mdma in rodents.
and toxicity-wise 5-iai is compared to 4-iodo-amphetamine, which is being used in the lab to selectively kill serotonogenic neurons. i'd be careful around this one and wait until more reports (and research) are available.
mdai also did fully substitute for mdma in rodents.
and toxicity-wise 5-iai is compared to 4-iodo-amphetamine, which is being used in the lab to selectively kill serotonogenic neurons. i'd be careful around this one and wait until more reports (and research) are available.
A rigid analogue, 5-iodo-2-aminoindan (5-IAI), of the serotonin neurotoxic halogenated amphetamine p-iodoamphetamine (PIA) was pharmacologically evaluated for production of serotonin neurotoxicity. A comparison was also made between 5-IAI and PIA in the two-lever drug discrimination paradigm in rats trained to discriminate saline from 3,4-methylenedioxymethamphetamine (MDMA) or saline from the alpha-ethyl homologue of MDMA, MBDB. PIA and 5-IAI were both behaviorally active, and fully substituted in both groups of animals, but were considerably less potent than p-chloroamphetamine (PCA). PIA had about twice the potency of PCA as an inhibitor of [3H]-5-HT uptake in rat brain cortical synaptosomes, while 5-IAI was only about 75% as potent as PCA in this assay. A single 40 mg/kg dose of PIA resulted in a 40% reduction of 5-HT and 5-HIAA levels and in the number of 5-HT uptake sites in rat cortex at one week sacrifice. The same dose of 5-IAI with one week sacrifice led to about a 15% decrease in 5-HIAA levels and number of 5-HT uptake sites, but only the latter was statistically significant. In rat hippocampus, PIA gave significant decreases in all serotonin markers examined, while 5-IAI slightly but significantly decreased only 5-HT levels. Neither compound produced any change in catecholamine or catecholamine metabolite levels. The results confirm earlier reports of the selective serotonin neurotoxicity of PIA, which is less severe than that of PCA, and also demonstrate that its rigid analogue 5-IAI does not appear to cause significant serotonin deficits in the rat.